产品详情
Targets
Target | Value |
---|---|
FGFR1 | IC50: ~25nM |
VEGFR2 | IC50: 100nM-200nM |
c-Src | IC50: 19.8μM |
EGFR | IC50: >50μM |
Insulin Receptor | IC50: >50μM |
MEK | IC50: >50μM |
PKC | IC50: >50μM |
In vitro (25°C) | DMSO | 86 mg/mL (164.22 mM) | |
Water | Insoluble | ||
Ethanol | 86 mg/mL (164.22 mM) | ||
In vivo | 5% DMSO+corn oil | 14 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 19.09 mL | 95.47 mL | 190.95 mL |
0.5 mM | 3.82 mL | 19.09 mL | 38.19 mL |
1 mM | 1.91 mL | 9.55 mL | 19.09 mL |
5 mM | 0.38 mL | 1.91 mL | 3.82 mL |
*The above data is based on the productmolecular weight 523.7 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
目录号 | A10703 |
---|---|
作用机制 | Inhibitor (抑制剂) |
M. Wt | 523.7 |
Formula | C28H41N7O3 |
Purity | >99% |
Storage | Store lyophilized at -20ºC, keep desiccated. |
CAS No. | 219580-11-7 |
Synonyms | PD-173074 |
SMILES | CCN(CC)CCCCNC1=NC2=NC(=C(C=C2C=N1)C3=CC(=CC(=C3)OC)OC)NC(=O)NC(C)(C)C |
产品标签
Product Questions
Product Questions
Alofanib (RPT835)
Alofanib (RPT835)是FGFR2的强效选择性变构抑制剂,具有潜在的抗癌活性。
Pazopanib (GW-786034)
Pazopanib (GW-786034)是VEGFR-1,VEGFR-2,VEGFR-3,PDGFR-a/β和c-kit的有效且选择性的多靶点酪氨酸激酶抑制剂,可阻…
NVP-BGJ398 phosphate
NVP-BGJ398 phosphate是一种新型的选择性泛特异性FGFR抑制剂,对FGFR1,FGFR2和FGFR3的IC50分别为0.9、1.4和1 nM。与FGF…
Pazopanib HCl (GW786034)
Pazopanib HCl (GW786034)是VEGFR-1,VEGFR-2,VEGFR-3,PDGFR-a/β和c-kit的有效且选择性的多靶点酪氨酸激酶抑制剂,可…
Debio-1347 (CH5183284)
Debio-1347 (CH5183284)是成纤维细胞生长因子受体亚型1(FGFR-1),2(FGFR-2)和3(FGFR-3)的生物利用抑制剂,具…
Erdafitinib (JNJ-42756493)
Erdafitinib (JNJ-42756493)是一种有效且选择性的口服生物利用型泛成纤维细胞生长因子受体(FGFR)抑制剂,具…
LY 2874455
LY2874455是一种新型有效的FGFR / VEGFR抑制剂。